APA (7th ed.) Citation

Sikiric, P., Seiwerth, S., Skrtic, A., Staresinic, M., Strbe, S., Vuksic, A., . . . Dobric, I. (2025). BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18 , 185. Pharmaceuticals (14248247), 18(10), 1450. https://doi.org/10.3390/ph18101450

Chicago Style (17th ed.) Citation

Sikiric, Predrag, et al. "BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak Et Al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18 , 185." Pharmaceuticals (14248247) 18, no. 10 (2025): 1450. https://doi.org/10.3390/ph18101450.

MLA (9th ed.) Citation

Sikiric, Predrag, et al. "BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak Et Al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18 , 185." Pharmaceuticals (14248247), vol. 18, no. 10, 2025, p. 1450, https://doi.org/10.3390/ph18101450.